We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$248M
AUM Growth
+$20.3M
Cap. Flow
+$11.1M
Cap. Flow %
4.46%
Top 10 Hldgs %
60.27%
Holding
778
New
287
Increased
55
Reduced
253
Closed
166

Sector Composition

Rank Sector Weight
1 Financials 4.11%
2 Healthcare 3.4%
3 Technology 2.45%
4 Industrials 2.35%
5 Consumer Discretionary 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGCO icon
376
AGCO
AGCO
$7.51B
$24K 0.01%
+397
New +$24K
AOK icon
377
iShares Core Conservative Allocation ETF
AOK
$796M
$24K 0.01%
+702
New +$24K
EOG icon
378
EOG Resources
EOG
$76.4B
$24K 0.01%
185
-514
-74% -$62.5K
FLOT icon
379
iShares Floating Rate Bond ETF
FLOT
$10.3B
$24K 0.01%
470
-205
-30% -$10.4K
IHF icon
380
iShares US Healthcare Providers ETF
IHF
$1.26B
$24K 0.01%
+600
New +$22.8K
LMBS icon
381
First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF
LMBS
$6.37B
$24K 0.01%
+480
New +$24.5K
PFG icon
382
Principal Financial Group
PFG
$24.7B
$24K 0.01%
411
-8
-2% -$446
RF icon
383
Regions Financial
RF
$27.3B
$24K 0.01%
+1,325
New +$24.9K
TDOC icon
384
Teladoc Health
TDOC
$1.22B
$24K 0.01%
+277
New +$19.7K
VFC icon
385
VF Corp
VFC
$5.99B
$24K 0.01%
269
-42
-14% -$3.58K
XBI icon
386
State Street SPDR S&P Biotech ETF
XBI
$9.92B
$24K 0.01%
+251
New +$24.3K
XLE icon
387
State Street Energy Select Sector SPDR ETF
XLE
$38.4B
$24K 0.01%
638
-58
-8% -$2.17K
LIT icon
388
Global X Lithium & Battery Tech ETF
LIT
$1.55B
$23K 0.01%
+688
New +$22.2K
DHR icon
389
Danaher
DHR
$137B
$22K 0.01%
232
-13
-5% -$1.18K
HCSG icon
390
Healthcare Services Group
HCSG
$1.59B
$22K 0.01%
+551
New +$22.9K
IBB icon
391
iShares Biotechnology ETF
IBB
$9.39B
$22K 0.01%
+181
New +$21.3K
MDLZ icon
392
Mondelez International
MDLZ
$79.2B
$22K 0.01%
521
-412
-44% -$17.6K
NGVT icon
393
Ingevity
NGVT
$2.6B
$22K 0.01%
218
TDG icon
394
TransDigm Group
TDG
$71.3B
$22K 0.01%
+60
New +$21.6K
AIMT
395
DELISTED
Aimmune Therapeutics
AIMT
$22K 0.01%
+800
New +$22.6K
AME icon
396
Ametek
AME
$58.2B
$21K 0.01%
264
+225
+577% +$17.2K
AYI icon
397
Acuity Brands
AYI
$10.4B
$21K 0.01%
+132
New +$18.9K
BAC icon
398
Bank of America
BAC
$440B
$21K 0.01%
710
-3,992
-85% -$122K
CAT icon
399
Caterpillar
CAT
$404B
$21K 0.01%
136
-198
-59% -$28K
IEZ icon
400
iShares US Oil Equipment & Services ETF
IEZ
$365M
$21K 0.01%
+600
New +$21.3K

Similar funds

Arax Advisory Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Arax Advisory Partners held 778 positions worth $248M, up 8.9% from $228M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Arax Advisory Partners deployed $11.1M of net new capital in Q3 2018, opening 287 new positions and adding to 55 existing holdings. Its largest new stake was iShares 1-5 Year Investment Grade Corporate Bond ETF: 389,577 shares worth $20.2M.

By sector, the portfolio is most concentrated in Financials at 4.1% of assets, down from 4.7% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $7.7M trimmed.

  • Arax Advisory Partners's largest Q3 2018 buy was iShares 1-5 Year Investment Grade Corporate Bond ETF: 389,577 shares worth $20.2M.
  • Arax Advisory Partners added most to PNC Financial Services in Q3 2018, an estimated $529K increase.
  • Arax Advisory Partners's biggest Q3 2018 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $7.7M.
  • Arax Advisory Partners fully exited iShares Russell Top 200 Growth ETF in Q3 2018, selling an estimated $209K.
  • Arax Advisory Partners's ten largest holdings make up 60% of its $248M portfolio in Q3 2018.
  • Arax Advisory Partners opened 287 new positions and closed 166 in Q3 2018.
  • Arax Advisory Partners's portfolio value rose 8.9% quarter-over-quarter to $248M.

Based on Arax Advisory Partners's 13F filing for Q3 2018, filed 6 Nov 2018.